These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17419138

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.
    J Infect Dis; 2007 Nov 15; 196(10):1500-8. PubMed ID: 18008230
    [Abstract] [Full Text] [Related]

  • 4. A missed point in deciphering the viral synergy between herpes simplex virus and HIV.
    Lisco A, Vanpouille C, Margolis L.
    Lancet Infect Dis; 2009 Sep 15; 9(9):522-3. PubMed ID: 19695487
    [No Abstract] [Full Text] [Related]

  • 5. HSV therapy and HIV-1 reduction.
    Martinez V, Caumes E.
    N Engl J Med; 2007 May 31; 356(22):2323; author reply 2324. PubMed ID: 17538093
    [No Abstract] [Full Text] [Related]

  • 6. HSV therapy and HIV-1 reduction.
    Eisenhut M.
    N Engl J Med; 2007 May 31; 356(22):2323-4; author reply 2324. PubMed ID: 17542070
    [No Abstract] [Full Text] [Related]

  • 7. Use of antiviral drugs to prevent herpesvirus transmission.
    Crumpacker CS.
    N Engl J Med; 2004 Jan 01; 350(1):67-8. PubMed ID: 14702430
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
    Mugwanya K, Baeten JM, Mugo NR, Irungu E, Ngure K, Celum C.
    J Infect Dis; 2011 Dec 15; 204(12):1912-7. PubMed ID: 21998479
    [Abstract] [Full Text] [Related]

  • 10. Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir.
    Roxby AC, Liu AY, Drake AL, Kiarie JN, Richardson B, Lohman-Payne BL, John-Stewart GC, Wald A, De Rosa S, Farquhar C.
    AIDS Res Hum Retroviruses; 2013 Jan 15; 29(1):94-8. PubMed ID: 22852760
    [Abstract] [Full Text] [Related]

  • 11. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.
    Baeten JM, Strick LB, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Magaret A, Wald A, Corey L, Celum C.
    J Infect Dis; 2008 Dec 15; 198(12):1804-8. PubMed ID: 18928378
    [Abstract] [Full Text] [Related]

  • 12. A pilot study examining the safety and tolerability of valacyclovir in veterans with hepatitis C virus/herpes simplex virus type 2 coinfection.
    Burton MJ, Penman A, Sunesara I, McGuire BM, Hook EW.
    Am J Med Sci; 2014 Dec 15; 348(6):455-9. PubMed ID: 25163019
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral valacyclovir in the treatment of acute retinal necrosis syndrome.
    Aslanides IM, De Souza S, Wong DT, Giavedoni LR, Altomare F, Detorakis ET, Kymionis GD, Pallikaris IG.
    Retina; 2002 Jun 15; 22(3):352-4. PubMed ID: 12055471
    [No Abstract] [Full Text] [Related]

  • 16. Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
    Baeten JM, Lingappa J, Beck I, Frenkel LM, Pepper G, Celum C, Wald A, Fife KH, Were E, Mugo N, Sanchez J, Essex M, Makhema J, Kiarie J, Farquhar C, Corey L.
    J Infect Dis; 2011 Jan 01; 203(1):117-21. PubMed ID: 21148504
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T, Harris J, Brennan CA.
    Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [Abstract] [Full Text] [Related]

  • 18. Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
    Brown TJ, McCrary M, Tyring SK.
    J Am Acad Dermatol; 2002 Oct 01; 47(4):581-99. PubMed ID: 12271305
    [Abstract] [Full Text] [Related]

  • 19. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul 01; 45():1698-700, 1703-5. PubMed ID: 10424269
    [Abstract] [Full Text] [Related]

  • 20. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK, Baker D, Snowden W.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.